跳至主要内容
临床试验/NCT00210236
NCT00210236终止3 期

Surgical Resection With or Without Axillary Lymph Node Excision in Treating Menopausal Women With Infiltrative Breast Cancer Smaller Than 10 mm

Institut Bergonié28 个研究点 分布在 1 个国家目标入组 625 人开始时间: 1995年9月1日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
625
试验地点
28
主要终点
Number of Deaths

研究概览

简要总结

This randomized phase III trial is studying surgery and axillary lymph node dissection to evaluate if systematic Axillary Lymph Node Excision can be avoided in locoregional treatment for operable breast cancer smaller than 10 mm among menopausal women older than 50

详细描述

Phase III randomized multicenter equivalence trial evaluating the role of Axillary Lymph Node Excision.

Primary aim is to assess if it is possible to avoid routine Axillary Lymph Node Excision during the initial treatment of breast cancers smaller than 11 mm in women aged 50 and older without compromising survival? The primary endpoint is overall survival: the event considered will be death from any cause.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of Deaths

时间窗: Five years after surgery

次要结局

  • Rate of Axillary Recurrence(Five years after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验